Mirae Asset Global Investments Co., Ltd.

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1569395 SEOUL, M5

Position in MLYS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$99,556

-$12,271 QoQ

Shares Held

3,690

-10.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#173

of 226 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. MLYS ranks #79 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$99,556	3,690	-10.6%	Shares	Sole	2026-07-22
2026-03-31	$111,827	4,128	+7.3%	Shares	Sole	2026-05-04
2025-12-31	$139,571	3,846	+50.1%	Shares	Sole	2026-01-26
2025-09-30	$97,188	2,563	+1.8%	Shares	Sole	2025-11-03
2025-06-30	$34,068	2,518	+51.0%	Shares	Sole	2025-07-21
2025-03-31	$26,487	1,668	+0.6%	Shares	Sole	2025-04-24
2024-12-31	$20,409	1,658	-7.8%	Shares	Sole	2025-01-27
2024-09-30	$21,785	1,799	+21.4%	Shares	Sole	2024-10-23
2024-06-30	$17,339	1,482	—	Shares	Sole	2024-07-30
No filing history on record for this holder in this stock.